Vident Investment Advisory’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-58,045
| Closed | -$331K | – | 1235 |
|
|
2023
Q1 | $331K | Buy |
58,045
+2,821
| +5% | +$16.1K | 0.01% | 920 |
|
|
2022
Q4 | $557K | Buy |
55,224
+20,274
| +58% | +$205K | 0.02% | 671 |
|
|
2022
Q3 | $723K | Sell |
34,950
-812
| -2% | -$16.8K | 0.02% | 681 |
|
|
2022
Q2 | $886K | Buy |
35,762
+13,540
| +61% | +$335K | 0.03% | 661 |
|
|
2022
Q1 | $862K | Buy |
22,222
+3,716
| +20% | +$144K | 0.02% | 750 |
|
|
2021
Q4 | $1.08M | Buy |
18,506
+2,023
| +12% | +$118K | 0.03% | 673 |
|
|
2021
Q3 | $977K | Sell |
16,483
-1,178
| -7% | -$69.8K | 0.03% | 686 |
|
|
2021
Q2 | $1.53M | Buy |
17,661
+841
| +5% | +$73K | 0.05% | 510 |
|
|
2021
Q1 | $1.39M | Sell |
16,820
-69
| -0.4% | -$5.69K | 0.05% | 516 |
|
|
2020
Q4 | $1.54M | Sell |
16,889
-24,781
| -59% | -$2.25M | 0.06% | 393 |
|
|
2020
Q3 | $1.67M | Sell |
41,670
-2,910
| -7% | -$116K | 0.08% | 301 |
|
|
2020
Q2 | $1.53M | Sell |
44,580
-32,314
| -42% | -$1.11M | 0.08% | 305 |
|
|
2020
Q1 | $1.71M | Sell |
76,894
-4,801
| -6% | -$107K | 0.11% | 217 |
|
|
2019
Q4 | $1.6M | Buy |
81,695
+1,274
| +2% | +$24.9K | 0.1% | 319 |
|
|
2019
Q3 | $1.25M | Sell |
80,421
-2,298
| -3% | -$35.7K | 0.11% | 141 |
|
|
2019
Q2 | $1.68M | Sell |
82,719
-13,596
| -14% | -$276K | 0.14% | 101 |
|
|
2019
Q1 | $1.69M | Sell |
96,315
-3,479
| -3% | -$61.1K | 0.09% | 316 |
|
|
2018
Q4 | $1.28M | Sell |
99,794
-94,906
| -49% | -$1.22M | 0.07% | 367 |
|
|
2018
Q3 | $3.17M | Sell |
194,700
-12,976
| -6% | -$211K | 0.12% | 215 |
|
|
2018
Q2 | $2.36M | Buy |
+207,676
| New | +$2.36M | 0.09% | 296 |
|